v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash $ 2,887,874 $ 1,038,952
Advances on research and development contract services
Prepaid insurance 29,490 20,898
Other prepaid expenses 61,839 85,653
Digital assets 2,454,473
Total current assets 5,433,676 1,145,503
Total assets 5,433,676 1,145,503
Current liabilities:    
Accounts payable and accrued expenses, including $112,033 and $27,500 to related parties at September 30, 2025 and December 31, 2024, respectively 235,900 83,206
Research and development contract liabilities 235,155 235,078
Series B Convertible Preferred Stock 8% cumulative dividend payable 50,367
Total current liabilities 521,422 318,284
Commitments and contingencies  
Stockholders’ equity:    
Common stock, $0.0001 par value; authorized – 100,000,000 shares; issued and outstanding – 5,704,200 and 2,249,290 shares at September 30, 2025 and December 31, 2024 570 225
Additional paid-in capital 57,891,644 49,394,687
Accumulated deficit (55,533,319) (52,067,693)
Total stockholders’ equity 4,912,254 827,219
Total liabilities and stockholders’ equity 5,433,676 1,145,503
Series A Convertible Preferred Stock [Member]    
Stockholders’ equity:    
Preferred stock, value $ 3,500,000
Series B Convertible Preferred Stock [Member]    
Stockholders’ equity:    
Preferred stock, value $ 2,553,359  

Source

HTML PDF
ZIP